|
At the time of the initial complaint, limited information was provided for the initial complaint.A neurosurgeon reported to the distributor that the product involved is duramatrix-onlay conform, noting that "four patients now have come back presenting with headaches and one had a seizure.In post-operation craniotomy scans, it showed inflammation around the dural graft site.The patient who presented with a seizure had fluid and was infected, leading to a take-back to the or a month later." the neurosurgeon noted "all cases were craniotomies."one was a tumor, meningioma, middle fossa/csf leak, and a subdural.This complaint pertains to patient #1, who underwent a craniotomy and subsequently experienced a headache.Additional information was received on 07/07/2025.The lot number and item number have been provided.The initial surgery was on (b)(6) 2025.The patient developed headaches and dysarthria roughly 1 week later.The patient presented to the emergency department (ed).Mr imaging showed dural enhancement around the operative site.There was a concern for seizures and the patient was started on medical therapy.Was monitored in the hospital for a few days and symptoms slowly and completely resolved.Patient overall did well.
|